Tc Biopharm Holdings Plc Net Income per Employee (TCBP), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Tc Biopharm holdings Plc  (TCBP)
 

Tc Biopharm Holdings Plc Net Income per Employee

TCBP's Quarterly Results, Trends, Rankings, Statistics
Tc Biopharm Holdings Plc recorded a cumulative net loss of $-12 million during 12 month ending in the fourth quarter 2024.
The Healthcare sector has seen employees of 33 other companies achieving higher income per employee. While Tc Biopharm Holdings Plc's total ranking has deteriorated compared to the previous quarter from 0 to 3341.


What is Income per Employee Ratio?






TCBP Net Income per Employee (Dec 31 2024)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2023)
IV. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -296,440 -144,072 -177,967 -177,967 -177,967
TCBP's Total Ranking # 3341 # 0 # 0 # 0 # 0
Seq. Net Income Change - - - - -


TCBP Net Income per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 34
Healthcare Sector # 398
Overall Market # 3341

Net Income per Employee Statistics
High Average Low
$ -33,895 $ -220,485 $ -331,120
(Dec 31 2022)   (Dec 31 2021)







Companies with similar Income per Employee for 12 month ending Dec 31 2024, within Healthcare Sector Income per Employee Income 12 month ending Dec 31 2024Number of Employees Dec 31 2024


Date modified: 2026-09-02T17:57:48+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.